Plain-English translation of NCT07460362 on ClinicalTrials.gov ↗ · Source last updated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
China
Sponsor
Peking University Third Hospital
Enrollment target
~43 participants
Started
August 2025
Primary completion
December 2027
Age range
18 Years – 80 Years
Last updated on clinicaltrials.gov in March 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Hongmei Jing
Peking University Third Hospital
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.